Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7 cells differentiating into osteoclasts by Qi Xiong et al.
Xiong et al. Proteome Science  (2015) 13:16 
DOI 10.1186/s12953-015-0073-6RESEARCH ARTICLE Open AccessProteomic study of different culture medium
serum volume fractions on RANKL-dependent
RAW264.7 cells differentiating into osteoclasts
Qi Xiong1†, Lihai Zhang1†, Lingli Xin3, Yanpan Gao2, Ye Peng1, Peifu Tang1* and Wei Ge2*Abstract
Background: Cultivation of osteoclasts is a basic tool for investigating osteolytic bone diseases. Fetal bovine serum
(FBS) is the standard supplement used for in vitro cell culture medium. Typically, the serum volume fraction used for
osteoclast cultivation is 10%. In this study, we investigated the use of a low serum (1% FBS) model for culturing
osteoclasts.
Results: To confirm the validity of this model for use in osteoclast research, we compared the capacity for
osteoclastogenesis and bone resorption of RANKL-induced RAW 264.7 cells cultured in medium supplemented with
10% FBS and 1% FBS. Osteoclasts were successfully generated in medium supplemented with 1% FBS, and exhibited
prolonged longevity and similar bone resorbing ability to those generated in medium supplemented with 10% FBS,
although the osteoclasts were smaller in size. Proteomics and bioinformatics analyses were performed to assess the
suitability of osteoclasts formed in low serum-containing medium for use in research focusing on osteoclast differentiation
and function. Our study demonstrated that a total of 100 proteins were differentially expressed in cells cultured in
medium containing 1% FBS, of which 29 proteins were upregulated, and 71 proteins were downregulated. Bioinformatics
analysis showed that the electron transport chain and oxidative phosphorylation pathways were downregulated
obviously; however, the osteoclast signaling pathway was unaffected. The data have been deposited to the
ProteomeXchange with identifier PXD001935.
Conclusion: Our study provides clear evidence of the validity of the low serum model for use in studying
RANKL-dependent osteoclasts differentiation and bone resorption with the advantage of prolonged survival time.
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Osteoclasts are bone resorbing cells that are formed by
the fusion of monocyte/macrophage cells induced by re-
ceptor activator of nuclear factor B ligand (RANKL),
which is a member of the tumor necrosis factor super-
family [1,2]. Arthritis, osteoporosis, bone metastasis and
other bone degrading diseases partially result from the
abnormal function or overactivation of osteoclasts [3-5].* Correspondence: pftang301@126.com; wei.ge@chem.ox.ac.uk
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unless otherwise stated.Given the critical role that osteoclasts play in such bone
diseases, many studies of osteoclasts have been conducted.
The cultivation of cells in vitro is an indispensable tool in
basic cell and molecular biology studies [6] and culturing
osteoclasts in vitro is an essential basis for exploring bone
metabolism and the mechanisms of bone diseases.
Due to the identification of the RANKL/RANK signal-
ing pathway as a crucial requirement for osteoclast for-
mation, mature osteoclasts can now be obtained in vitro.
Previously, in vitro models of osteoclast differentiation
were mainly based on primary cell cultures, such as
bone marrow macrophages, splenocytes, and peripheral
blood monocytes induced by M-CSF and RANKL, all of
which are poorly suited to molecular studies because of
their limited availability and failure to produce pure pop-
ulations of osteoclasts [7,8]. More recently, the mouseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cell line, is increasingly being used as a cellular model of
osteoclast formation and function [2,9]. To obtain ma-
ture osteoclasts, RAW 264.7 cells are cultured in
medium supplemented with FBS, and stimulated with
RANKL. Conventionally, the serum volume fraction
used is 10%; however, the use of varying serum concentra-
tions in the osteoclast culture system has been reported.
In fact, Vincent et al. demonstrated that RAW 264.7 cells
cultured in serum-deprived medium could differentiate
into tartrate resistant acid phosphatase (TRAP)-positive
multinucleated osteoclasts, and their resorptive activity
was significantly enhanced [10]. Nevertheless, the molecu-
lar changes associated with the differentiation were not
mentioned in this study. Thus, the effects of the culture
medium serum volume fraction on osteoclast formation
and bone resorbing ability are still poorly defined.
To address these issues, we evaluated RANKL-dependent
osteoclast formation (unless otherwise specified, osteoclast
formation refers to RANKL-dependent osteoclast forma-
tion in present study) in both the conventional (10% FBS)
and low serum (1% FBS) culture systems. The bone resorp-
tive activities of the osteoclasts were investigated and the
protein changes of RAW 264.7 cells cultured under both
sets of conditions were compared in proteomics analyses,
which provide a global view of protein expression changes
in cells. Herein, we determined that the low serum fraction
model did not interfere with the osteoclast signaling path-
ways and both culture systems could be used to obtain
osteoclasts. Thus, either culture system can be used for spe-
cific applications according to the duration and interven-
tion factors of the experiments.
Results
Osteoclastogenesis in medium supplemented with 10%
FBS and 1% FBS
To compare osteoclastogenesis under both sets of condi-
tions, RANKL-induced RAW 264.7 cells were cultured
in medium supplemented with 10% FBS or 1% FBS.
TRAP staining was performed to confirm the formation
of mature multinucleated osteoclasts. Osteoclast forma-
tion was observed in both media from Day 2. In medium
supplemented with 10% FBS, the number of osteoclasts
reached a peak on Day 3, with a subsequent rapid de-
cline. In contrast, the number of osteoclasts achieved a
maximum on Day 4 in the medium supplemented with 1%
FBS, with a subsequent marginal decline. Statistical analysis
demonstrated that the number of multinucleated osteo-
clasts formed in medium supplemented with 10% FBS was
slightly greater than that in medium supplemented with 1%
FBS during the first three days. Subsequently, more multi-
nucleated osteoclasts were generated in the medium sup-
plemented with 1% FBS compared with that containing
10% FBS. There were significantly more osteoclasts in thelow serum fraction medium on Days 4, 5, 6 and Day 9 (P <
0.001). Moreover, osteoclast debris was observed from Day
4 in medium supplemented with 10% FBS, but not until
Day 6 in the cultures using medium supplemented with 1%
FBS. Taken together, these observations showed that greater
numbers of osteoclasts were formed in medium supple-
mented with 1% FBS, and that these osteoclasts exhibited
prolonged survival compared with those formed in medium
supplemented with 10% FBS (Figures 1and 2).
Comparison of size of osteoclasts and area of resorbing
surface
In addition to the comparison of numbers, osteoclast
function was also compared. To compare the bone resorp-
tion capacity of osteoclasts formed in both culture sys-
tems, the size of osteoclasts and the area of the resorbing
surface were evaluated. Osteoclasts formed in medium
containing 10% FBS had increased in size dramatically by
Day 3, enlarging to a maximum size by Day 6, followed by
a reduction in size. In contrast, the size of osteoclasts
formed in medium containing 1% FBS increased continu-
ously to Day 7, and subsequently declined in size. Our
study showed that the size of osteoclasts formed in
medium supplemented with 10% FBS were significantly
larger than those formed in medium supplemented with
1% FBS from Day 3 to Day 6 (P-values, 0.018, 0.018, 0.016
and 0.008, respectively). Unexpectedly, osteoclasts formed
in medium containing 1% FBS were larger in size than
those formed in medium supplemented with 10% FBS
during the last three days of culture, especially on Day 7
(P = 0.049). In contrast to the cell size, the areas of the re-
sorbing surfaces were similar under both sets of culture
conditions (P = 0.753). In general, the mean size of osteo-
clasts was larger in the medium supplemented with 10%
FBS from Day 2 to Day 6, while osteoclasts were larger
during the last 3 days of culture in medium containing 1%
FBS. However, there were no obvious differences in bone
resorptive capacity between the osteoclasts formed under
both sets of culture conditions (Figures 2 and 3).
Identification and classification of differentially expressed
proteins
Proteomics analysis was conducted to evaluate the differ-
ential expression of proteins in RAW 264.7 cells cultured
in medium supplemented with 10% FBS or 1% FBS. A
total of 6,403 RAW264.7 cell proteins were identified in
our study. A total of 100 differentially expressed proteins
were identified by comparing the cells cultured under the
two sets of conditions. Of these, 29 proteins were upregu-
lated and 71 were downregulated in cells cultivated in
medium with 1% FBS (Additional file 1). The PANTHER
online analysis toolkit was used to classify the differentially
expressed proteins. Eighty-five of 100 altered proteins
were identified as hits in 21 categories of protein class in
Figure 1 TRAP staining of RANKL-stimulated RAW264.7 cells in medium supplemented with 1% FBS and 10% FBS for 9 consecutive days. Multinucleated
osteoclasts were apparently observed on Day 3 in both culture conditions. Osteoclasts formed in medium supplemented with 10% FBS were larger in size
than those formed in medium supplemented with 1% FBS. Osteoclast debris was observed from Day 4 in medium supplemented with 10% FBS, but not
until Day 6 in the cultures using medium supplemented with 1% FBS.
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the greatest number of differentially expressed proteins
were transporter (PC00227), nucleic acid binding
(PC00176), and hydrolase (PC00121). Furthermore, we an-
alyzed the molecular functional processes in which the dif-
ferentially expressed proteins were involved. Of 100
altered proteins, 70 hits in eight categories of molecular
function were identified in the PANTHER online database,
with the majority of the proteins participating in catalytic
activity (GO:003824), binding (GO:000548), and trans-
porter activity (GO:0005215) (Figure 4).
Bioinformatics analysis of differentially expressed
proteins
To investigate the molecular mechanisms underlying
the differences between the osteoclasts formed under
the two sets of conditions, we conducted bioinformatics
analysis and visualization of the altered proteins with
WebGestalt online tools and Cytoscape software. Only
the electron transport chain pathway, in which only nine
of the 100 altered proteins were involved, was identified in
enrichment analysis based on the WikiPathways database.
In addition, KEGG enrichment analysis highlighted six
pathways, of which the metabolic pathway and oxidativephosphorylation involved 13 and 6 of 100 altered proteins,
respectively, while three of the pathways were related to
neurological diseases and one was associated with cardiac
muscle contraction (Table 1). Cytoscape software was then
used to visualize all the osteoclast signaling proteins
identified in the WikiPathways database. Osteoclast bio-
markers such as TRAP, RANK, cathepsin K were all
slightly decreased (Figure 5), while osteopontin (OPN), a
potent stimulator of osteoclastogenesis and resorptive
activity [11], was slightly upregulated, suggesting that
osteoclast bone resorptive activity was compromised to an
extent. Cytoscape software was then used to visualize
pathways involving the differentially expressed proteins. In
the electron transport chain pathway, all nine proteins
identified as hits in the WikiPathways database were
downregulated, indicating inhibition of that pathway of
energy production (Figure 6).
Discussion
Fetal bovine serum (FBS) is a cocktail of numerous factors
required for cell maintenance, and is utilized routinely to
supplement medium for in vitro cultivation of numerous
cell-types, including osteoclasts [12]. Culture media are
typically supplemented with 10% FBS [12,13]; however,
Figure 2 Comparison of TRAP-positive cell numbers and size of osteoclasts formed in medium supplemented with 10% FBS and 1% FBS.
(A): significantly more osteoclasts were observed in 1% FBS medium on Days 4, 5, 6 and 9; (B): the number of osteoclasts reached a maximum in
10% FBS medium on Day 3, after which the numbers declined dramatically, while the number of osteoclasts reached a maximum in 1% FBS
medium on Day 4 and subsequently decreased moderately. (C): Osteoclasts formed in 10% FBS medium were obviously larger on Days 3, 4, 5
and 6, while osteoclasts formed in 1% FBS medium were significantly larger on Day 7. (D): Osteoclasts formed in 10% FBS medium reached
maximum size on Day 6, while osteoclasts formed in 1% FBS medium reached maximum size on Day 7. *: P < 0.05.
Figure 3 Bone resorptive capacity of osteoclasts was compared on Day 9. Toluidine blue staining was performed. (A): resorptive pits formed by
osteoclasts cultured in 1% FBS medium. (B): resorptive pits formed by osteoclasts cultured in medium with 10% FBS. (C): no difference in the area
of resorptive pits was observed between the two culture conditions.
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Figure 4 Classification of differentially expressed proteins using the PANTHER Classification System online. (A): 21 categories of protein class hits
identified in the PANTHER Protein Class Database. (B): eight categories of molecular function hits identified in the GO Molecular Function database.
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microenvironment.
In the present study, osteoclast formation was investi-
gated in medium supplemented with 1% FBS, which
simulates physiological conditions more closely than
10% FBS. Here, we demonstrate the successful formation
of osteoclasts with similar bone resorbing ability from
RANKL-induced RAW264.7 cells cultured in media sup-
plemented with either 10% FBS or 1% FBS. However, lar-
ger osteoclasts were formed more rapidly in medium
supplemented with 10% FBS compared with those
formed using the low serum model, while the longevity of
the osteoclasts was less prolonged. Subsequent proteomicsanalysis of the molecular mechanisms underlying these
differences revealed a total of 100 differentially expressed
proteins involved in 12 biological processes. Of these, 29
proteins were upregulated and 71 were downregulated.
However, no significant changes in the expression of
proteins involved in osteoclastogenesis pathways were
detected.
Osteoclasts are formed in the monocyte/macrophage
lineage from hematopoietic progenitors. Osteoclasto-
genesis includes a number of steps comprised of survival,
differentiation, fusion and activation [14]. Extensive inves-
tigations have demonstrated that the RANKL-mediated
signaling pathway and downstream transcription factors
Table 1 Enriched KEGG pathways analysis
Pathway name Gene EntrezGene Statistics
Huntington's disease 9 12858 11740 22335 66142 67264 14775
17709 22333 20463
C = 197;O = 9;E = 0.27;R = 33.89;rawP = 7.62e-12;adjP = 1.37e-10
Parkinson's disease 8 12858 11740 22335 66142 67264 17709
22333 20463
C = 148;O = 8;E = 0.20;R = 40.10;rawP = 3.05e-11;adjP = 2.75e-10
Metabolic pathways 13 12858 56012 18263# 14085# 18770# 66142 13200
208715# 67264 27425 20018# 110196# 17709
C = 1184;O = 13;E = 1.60;R = 8.14;rawP = 6.66e-09;adjP = 4.00e-08
Oxidative phosphorylation 6 67264 12858 27425 17709 66142 20463 C = 147;O = 6;E = 0.20;R = 30.28;rawP = 5.36e-08;adjP = 2.41e-07
Cardiac muscle contraction 4 12858 17709 66142 20463 C = 81;O = 4;E = 0.11;R = 36.63;rawP = 4.70e-06;adjP = 1.69e-05
Alzheimer's disease 5 67264 12858 17709 66142 20463 C = 188;O = 5;E = 0.25;R = 19.73;rawP = 5.98e-06;adjP = 1.79e-05
•C: the number of reference genes in the category.
•O: the number of genes in the gene set and also in the category.
•E: the expected number in the category.
•R: ratio of enrichment.
•rawP: P-value from hypergeometric test.
•adjP: P-value adjusted by the multiple test adjustment.
•#: the genes upregulated.
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RANKL performs crucial regulation of osteoclastogenesis
mediated by binding to its receptor, RANK, leading to the
expression of a variety of osteoclast genes including TRAP,
cathepsin K, calcitonin receptor, αvβ3-integrin and MMP-
9 [15,16]. During osteoclastogenesis, RANKL induces the
recruitment of TNF receptor-associated cytoplasmic factor
6 (TRAF6), which subsequently stimulates downstream
signaling pathways, including IκB kinase (IKK), nuclear
factor κB (NF-κB), c-Jun N-terminal kinase (JNK), Akt,Figure 5 Visualization of all the proteins in the osteoclast signaling pathwa
proteins not identified in our study; green boxes indicate downregulated p
adjusted to indicate the ratio value.c-Src, p38, ERK, activator protein 1 (AP-1), and nuclear
factor and activator of transcription (NFATc1) [17,18]. No
significant changes in the expression of these proteins
were detected in this study, and the bone resorption cap-
acity of osteoclasts formed under the two sets of condi-
tions was similar. Hence, our results indicate that low
serum medium does not change the expression of osteo-
clast biomarkers. In accordance with the observations re-
ported by Vincent et al. [10], the osteoclasts formed in
low serum medium in our study were smaller than thoseys identified in the WikiPathways database. Gray boxes indicate
roteins; red boxes indicate upregulated proteins. Color intensity is
Figure 6 Visualization of differentially expressed proteins in the ETC. pathway pathways identified in the WikiPathways database. Gray boxes
indicate proteins not identified as differentially expressed proteins; green boxes indicate downregulated proteins. Color intensity is adjusted to
indicate the ratio value.
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gether, these observation indicate that osteoclasts formed
in both mediums are similar, and confirm the validity of
their use in research focusing on osteoclast differentiation
and function.
Notably, our results revealed a significant difference in
the size of osteoclasts generated in the two types of
media. Therefore, we performed proteomics analysis and
bioinformatics analysis to elucidate the molecular mech-
anisms underlying this difference. Our results clearly
demonstrate downregulation of the electron transport
chain (ETC.) and oxidative phosphorylation pathways,
both of which are essential for ATP synthesis, in osteo-
clasts formed under low serum conditions. Previous stud-
ies have indicated that osteoclast formation is an energy
consuming processes [19,20]. An et al. suggested that me-
tabolism and re-direction of energy flow plays a critical
role in osteoclast formation [21]. Therefore, we imply that
energy restriction partially contributed to the small size of
osteoclasts formed in medium supplemented with 1%
FBS. Additionally, studies have shown that perturbations
in some mitochondrial ETC. complexes increase lifespan
[22-24]. Thus, it can be speculated that these reports
explain our observation that osteoclasts formed in mediumcontaining 1% FBS exhibited prolonged long-term survival,
which might be beneficial for transgene studies of
osteoclasts.
Previous studies have shown that increased mitochon-
drial ETC. activity enhances bone resorption by osteo-
clasts [25]; however, in our study, no differences in the
bone resorption ability of osteoclasts formed under both
sets of conditions were observed despite the downregu-
lation in ETC. activity observed under low serum condi-
tions. This may be due to the hypoxic conditions under
which osteoclasts were cultured in the previous study.
Knowles et al. reported that osteoclasts exposed to a
constant hypoxic environment exhibited increased bone
resorption ability in a HIF-1α-dependent manner [26].
Furthermore, Muzylak et al. found that osteoclasts gen-
erated in hypoxia showed an eight-fold increase in size
compared with those cultured in normoxia [27]. More-
over, bone resorption requires osteoclast attachment to
bone surfaces and the formation of the ruffled border by
αvβ3 and small Rho family GTPases [28]. H+ ions are
then pumped through the ruffled border to demineralize
inorganic materials, and cathepsin K is secreted to digest
organic materials [29]. No significant differences in the ex-
pression of these proteins were detected in the current
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affect the bone resorption capacity of osteoclasts. In
addition, we found that OPN was slightly upregulated,
which might compromise ETC. activity. It is worth noting
that researchers studying osteoclast energy metabolism
should avoid culturing osteoclasts in low serum medium
due to the interference in the metabolic and ETC.
pathways.
Conclusions
In summary, compared with the typical culture conditions
of medium supplemented with 10% FBS, cultivation of
under low serum conditions (1% FBS) is associated with
changes in a number of biological pathways in RAW 264.7
cells and influences osteoclasts formation without affecting
bone resorption ability. Moreover, osteoclasts formed in
medium supplemented with 1% FBS exhibited extended
longevity. Accordingly, low serum conditions are suitable
for studies requiring prolonged osteoclast survival, while
these conditions should be avoided for studies of osteoclast
metabolism. Our study provides an alternative model for
studying osteoclast differentiation and bone resorption.
Materials and methods
Cells and reagents
RAW 264.7 cells were obtained from the Chinese Academy
of Medical Sciences (Beijing, China). α-MEM (11095–080)
and FBS (26140079) were obtained from Life Technologies.
Recombinant mouse RANKL (462-TEC-010) was pur-
chased from R&D Systems. Acid Phosphatase Leukocyte
Kits (387–1) were purchases from Sigma Aldrich. Urea
(17-1319-01) was obtained from GE healthcare. Protease
inhibitor cocktails were obtained from Roche. TMT six-
plex Isobaric Label Reagent Set (90061) was purchased
from Thermo Scientific. Trypsin/Lys-C Mix (V5072) was
purchased from Promega. BCA Protein Assay Kits
(23227) were obtained from Thermo Scientific. Osteo
Assay Surface 24 Well Plate (3987) was purchased from
Corning.
RAW264.7 cell cultivation and osteoclastogenesis
RAW 264.7 cells at a density of 1.5 × 105 cells/ml in
6-well plates were cultured in α-MEM supplemented with
either 10% (v/v) or 1% (v/v) FBS at 37°C in a 5% CO2 in-
cubator; both groups were prepared in triplicate. On the
next day, RAW 264.7 cells were harvested and used for
subsequent proteomics analysis; the triplicates of each
group were pooled and prepared for TMT labeling. To
generate mature multinucleated osteoclasts, 30 ng/ml
RANKL was added to both culture systems in 24-well
plates. Cells were cultured for 9 days; both conditions
were prepared in triplicate. The culture medium was
refreshed every other day.TRAP staining
TRAP staining was performed to confirm the formation of
mature osteoclasts. Mature osteoclasts were defined as
TRAP-positive cells containing three of more nuclei. TRAP
staining was performed using the Acid Phosphatase
Leukocyte kit according to the manufacturer’s instructions.
The number of TRAP-positive multinucleated osteoclasts
was counted using inverted microscopy. Furthermore, the
mean size of TRAP-positive multinucleated osteoclasts was
calculated with Adobe Photoshop CS3 software in three
random visual fields for each group.
Osteoclast resorption pit assay
An Osteo Assay Surface 24 Well Plate was used to
evaluate the bone resorptive activities of osteoclasts. On
Day 9, the medium from the wells was aspirated and
100 μl of 10% bleach solution was added to each well
and incubated for 5 minutes. Toluidine blue staining
was then performed to improve the contrast for re-
sorbed pit image analysis. NIH Image J software was
used to assess the total area of the resorbed pits.
Sample preparation and TMT labeling
Sample preparation and labeling were performed as de-
scribed previously [30]. In brief, cells were washed with
cold PBS three times followed by the addition of lysis
buffer. Cell lysates were clarified by centrifugation at
16,000 g for 10 minutes at 4°C. Supernatants were ob-
tained and protein concentrations were measured with
the BCA Protein Assay Kit. Then, 100 μg of protein was
incubated in 10 mM dithiothreitol at 50°C for 1 h.
Thereafter, proteins were incubated with 25 mM indole
acetic acid in the dark for 2 h. Proteins were then
digested with trypsin/ Lys-C Mix at a protein/protease
ratio of 25:1 and incubated overnight at 37°C. The TMT
Isobaric Label Reagent Set was used to labeling proteins
following the manufacturer’s manual protocol. The pro-
teins extracted from cells cultured in medium with 10%
FBS or 1% FBS were labeled with 0.8 mg TMT6-126 or
TMT6-127, respectively. Equal amounts of the labeled
protein digests from each group were combined for
mass spectrometry (MS) analysis.
High-performance liquid chromatography (HPLC)
Fractionation of combined protein digests was conducted
as described previously [31]. Briefly, the combined TMT
labeled samples were dissolved in 100 μl 0.1% FA and
transferred to a MS tube for HPLC analysis (UltiMate 3000
UHPLC, Thermo Scientific) using an Xbridge BEH300 C18
column (4.6 × 250 mm2, 5 μm, 300 Å, Waters). Fifty frac-
tions were collected into microtubes at 1.5 min intervals.
The fractions were dried under vacuum and dissolved in
20 μl 0.1% FA for further LC-MS/MS analysis.
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LC-MS/MS was performed using a Q Exactive mass spec-
trometer. Following separation using a 120 min gradient
elution at a flow rate of 0.3 μl/min using UltiMate 3000
RSLCano System (Thermo Scientific), the protein digests
were analyzed with a directly interfaced Q Exactive Hybrid
Quadrupole-Orbitrap Mass Spectrometer (Thermo Scien-
tific). A home-made fused silica capillary column (75 μm×
150 mm, Upchurch, Oak Harbor, WA, USA) packed with
C18 resin (300 Å, 5 μm, Varian Lexington, MA, USA) was
used as the analytical column. Xcalibur 2.1.2 software was
used with the Q Exactive mass spectrometer in data-
dependent acquisition mode. Ten data-dependent MS/
MS scans at 27% normalized collision energy (HCD)
were performed, after which, a single full-scan mass
spectrum in Orbitrap (400–1,800 m/z, 60, 000 resolution)
was conducted.
Statistical analysis
Osteoclast numbers in five random fields viewed under
light microscopy were counted in both groups from Day
1 to Day 9. Furthermore, the mean size of mature osteo-
clasts and the total area of the resorbed pits were
assessed with Adobe Photoshop CS3 and Image J soft-
ware. Statistical differences between parametric data sets
were assessed using Student’s t-test. A value of P < 0.05
was considered to indicate statistical significance.
LC-MS/MS data were analyzed using the Thermo
Scientific Proteome Discoverer software suite 1.3 with
the SEQUEST search engine and the mouse FASTA
database from UniProt (released on July 9, 2014). At
least 1 unique peptide per protein had to be identified
to list the protein as a hit. In the SEQUEST search en-
gine, full trypsin specificity was selected, two missed
cleavages were allowed, carbamidomethylation (C) and
TMT 6-plex (K and peptide N-terminal) were set as the
static modification, oxidation (M) was set as the dy-
namic modification, precursor ion mass tolerances were
set at 20 ppm for all MS data acquired using an Orbi-
trap mass analyzer, and the fragment ion mass toler-
ance was set as 20 mmu for all MS/MS spectra
acquired. The ratio of proteins labeled with TMT6-127
and TMT6-126 was adjusted using the β-actin ratio
value as the internal control. The thresholds for down-
regulation and upregulation were set at 0.6 and 1.7
respectively. In addition, the UniprotKB/Swiss-Prot ac-
cession numbers were converted into Entrez Gene ID
for subsequent analysis using UniProt online ID Map-
ping. The PANTHER Classification System online was
used to classify the proteins. The WebGestalt online
toolkit was used to conduct enrichment analysis. Cytos-
cape 3.1.1 software was used to visualize the protein-
protein interactions matching the online pathway database
and the significance level was set at 0.0001. The massspectrometry proteomics data have been deposited to the
ProteomeXchange Consortium [32] via the PRIDE partner
repository with the data identifier PXD001935.
Additional file
Additional file 1: Details of differentially expressed proteins
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